2021
DOI: 10.1002/cmdc.202100467
|View full text |Cite
|
Sign up to set email alerts
|

Inhibitors of Human Divalent Metal Transporters DMT1 (SLC11A2) and ZIP8 (SLC39A8) from a GDB‐17 Fragment Library

Abstract: Dedicated to the memory of Prof. François DiederichSolute carrier proteins (SLCs) are membrane proteins controlling fluxes across biological membranes and represent an emerging class of drug targets. Here we searched for inhibitors of divalent metal transporters in a library of 1,676 commercially available 3D-shaped fragment-like molecules from the generated database GDB-17, which lists all possible organic molecules up to 17 atoms of C, N, O, S and halogen following simple criteria for chemical stability and … Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
3
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 58 publications
0
3
0
Order By: Relevance
“…In addition, an increased level of the iron-import protein DMT1 was observed in NAFLD subjects, and some DMT1 inhibitors have been designed ( 146 ). However, in the treatment of NAFLD, these inhibitors could not exert satisfactory effects ( 148 ). Therefore, great efforts are warranted to develop more effective inhibitors targeting iron-import proteins and enhancers targeting iron-export proteins, which can reduce intestinal iron absorption and block ferroptosis, thus conferring protection against NAFLD.…”
Section: Potential Effective Therapies Targeting Ferroptosis For Nafldmentioning
confidence: 99%
“…In addition, an increased level of the iron-import protein DMT1 was observed in NAFLD subjects, and some DMT1 inhibitors have been designed ( 146 ). However, in the treatment of NAFLD, these inhibitors could not exert satisfactory effects ( 148 ). Therefore, great efforts are warranted to develop more effective inhibitors targeting iron-import proteins and enhancers targeting iron-export proteins, which can reduce intestinal iron absorption and block ferroptosis, thus conferring protection against NAFLD.…”
Section: Potential Effective Therapies Targeting Ferroptosis For Nafldmentioning
confidence: 99%
“…A ZIP8 inhibitor, (S)-6-chloro-2,3,4,9-tetrahydro-1H-carbazol-1-amine was identified by Cd 2+ -uptake assay in the cells transiently expressing ZIP8 (IC 50 = 17.2 μM). This compound showed cross reactivity to two zinc transporters ZIP2 and ZIP14, and to four membrane proteins, serotonin receptor (5-HT2A), dopamine transporter, serotonin transporter and ERG potassium channel [ 71 ]. As food ingredients that can affect the expression of zinc transporter, soyasaponin Bb which is extracted from soybeans decreased zinc-induced mouse ZIP4 (mZIP4) endocytosis and increased the protein expression of both mouse and human ZIP4 and the intracellular zinc levels [ 72 ].…”
Section: Therapeutic Perspectivesmentioning
confidence: 99%
“…Therefore, restricting dietary iron supplements or inhibiting iron absorption could be a potential therapeutic option for iron overload diseases [75]. Hence, several DMT1 inhibitors have been designed [76] , but their efficacy is still awaiting elucidation, especially in NAFLD-related liver diseases. In addition, protecting intestinal epithelial cells from inflammatory injury [39] and maintaining gut microbiome homeostasis [77] are potential therapeutic strategies.…”
Section: Targeting Iron Availabilitymentioning
confidence: 99%